← Back to Deal Tracker

Cornerstone investors (e.g., Eli Lilly, Tencent, Temasek, Schroders, UBS AM, Oaktree, E Fund, Taikang Life) Deals

Corporate entity

Why Track Cornerstone investors (e.g., Eli Lilly, Tencent, Temasek, Schroders, UBS AM, Oaktree, E Fund, Taikang Life)

Cornerstone investors (e.g., Eli Lilly, Tencent, Temasek, Schroders, UBS AM, Oaktree, E Fund, Taikang Life) has 1 deal worth Undisclosed, making them a major investor in the AI industry. They've backed 1 company.

Total Deals

1

Total Value

Undisclosed

As Investor

1

As Recipient

0

Deals as Investor/Acquirer (1)

↗
Public market investors (Hong Kong public tranche and international offering)→Insilico Medicine
as Investor

Insilico Medicine raised roughly HK$2.28 billion (over US$290 million) in a heavily oversubscribed Hong Kong IPO, the largest biotech flotation in the city in 2025.

Undisclosed

Dec 31, 2025

View Details →

Explore by Deal Type

Investment DealsAcquisition DealsHardware DealsCompute DealsIntegration DealsPartnership DealsLicensing DealsResearch Deals
View Cornerstone investors (e.g., Eli Lilly, Tencent, Temasek, Schroders, UBS AM, Oaktree, E Fund, Taikang Life) Company Profile→
View Cornerstone investors (e.g., Eli Lilly, Tencent, Temasek, Schroders, UBS AM, Oaktree, E Fund, Taikang Life) Profile →